Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
Dark Blue Therapeutics was acquired for $840 million by Amgen in the USA

Dark Blue Therapeutics was acquired for $840 million by Amgen in the USA

Biotech Manufacturing

United Kingdom

United States

Secondary

06 December 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

Dark Blue Therapeutics (company)

United Kingdom

Biotech Manufacturing

Total investments received (USD): 4M

Related deals

Tropic raised a $105 million Series C led by Forbion and Corteva, joined by IQ Capital, Just Climate, ABN Amro, Invest International, Temasek, Five Seasons

Agriculture Biotech Manufacturing

France

United Kingdom

Netherlands

United States

Singapore

Investments 13 March 2026

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2026. Made with in Stockholm

Top